Patient no. | Distance of sample from target (mm) | Micronecrosis index (%) | Target 201TI index | Target WHO tumor grade | Target Ki67 index (%) | Target MI |
---|---|---|---|---|---|---|
1* | −10, −5, 0 | 100 (3/3) | 1.2 | Astrocytoma II | Necrosis | Necrosis |
−5, 0 | 50 (1/2) | 2.0 | Astrocytoma II | 2 | 1 | |
2 | −29, −16, −10, −5, 0, +1 | 25 (2/8) | 3.7 | Oligoastrocytoma III | 52 | 12 |
3 | −20, −17.5, −15, −9, −5, 0, +5 | 75 (2/8) | 4.1 | Glioblastoma IV | Necrosis | Necrosis |
4* | −10, −5, 0 | 0 (0/3) | 3.9 | Glioblastoma IV | 24 | 10 |
−5, 0 | 0 (0/2) | 5.5 | Glioblastoma IV | 25 | 8 | |
5 | −20, −15, −10, −5, 0, +5, +10 | 0 (0/7) | 6.2 | Anaplastic oligodendroglioma III | 13 | 3 |
6 | −10, −5, 0, +5, +10 | 0 (0/5) | 10.0 | Neuroendocrine metastasis | 59 | 10 |
7 | −9, −5, 0 | 0 (0/3) | 8.25 | Anaplastic astrocytoma III | 40 | 7 |
8 | −18, −12, −10, −5, 0, +5 | 0 (0/6) | 3.67 | Glioblastoma IV | 80 | 27 |
9 | −30, −20, −15, −10, −5, 0 | 0 (0/5) | 3.30 | Oligodendroglioma III | 56 | 4 |
10 | −8, 0, +5, +10, +15 | 0 (0/5) | 6.17 | Glioblastoma multiform IV | 52 | 51 |
↵* Two different trajectories were analyzed for this patient.
MI = mitotic index.